Eastham JA, Boorjian SA, Kirkby E (2022) Clinically localized prostate cancer: AUA/ASTRO Guideline. J Urol 208:505–507

PubMed  Google Scholar 

Chen RC, Basak R, Meyer AM et al (2017) Association between choice of radical prostatectomy, external beam radiotherapy, brachytherapy, or active surveillance and patient-reported quality of life among men with localized prostate cancer. JAMA 317:1141–1150

PubMed  PubMed Central  Google Scholar 

Tan WP, Chang A, Sze C, Polascik TJ (2021) Oncological and functional outcomes of patients undergoing individualized partial gland cryoablation of the prostate: a single-institution experience. J Endourol 35:1290–1299

PubMed  PubMed Central  Google Scholar 

Reddy D, Peters M, Shah TT et al (2022) Cancer control outcomes following focal therapy using high-intensity focused ultrasound in 1379 men with nonmetastatic prostate cancer: a multi-institute 15-year experience. Eur Urol 81:407–413

PubMed  Google Scholar 

Ahmed HU, El-Shater Bosaily A, Brown LC et al (2017) Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet 389:815–822

PubMed  Google Scholar 

Lebastchi AH, George AK, Polascik TJ et al (2020) Standardized nomenclature and surveillance methodologies after focal therapy and partial gland ablation for localized prostate cancer: an international multidisciplinary consensus. Eur Urol 78:371–378

PubMed  PubMed Central  Google Scholar 

Turkbey B, Rosenkrantz AB, Haider MA et al (2019) Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2. Eur Urol 76:340–351

PubMed  Google Scholar 

Panebianco V, Villeirs G, Weinreb JC et al (2021) Prostate magnetic resonance imaging for local recurrence reporting (PI-RR): international consensus -based guidelines on multiparametric magnetic resonance imaging for prostate cancer recurrence after radiation therapy and radical prostatectomy. Eur Urol Oncol 4:868–876

PubMed  Google Scholar 

Giganti F, Dickinson L, Orczyk C et al (2023) Prostate imaging after focal ablation (PI-FAB): a proposal for a scoring system for multiparametric mri of the prostate after focal therapy. Eur Urol Oncol 6:629–634

PubMed  Google Scholar 

Tay KJ, Amin MB, Ghai S et al (2019) Surveillance after prostate focal therapy. World J Urol 37:397–407

PubMed  Google Scholar 

Tay KJ, Polascik TJ (2016) Focal cryotherapy for localized prostate cancer. Arch Esp Urol 69:317–326

CAS  PubMed  Google Scholar 

Weinreb JC, Barentsz JO, Choyke PL et al (2016) PI-RADS Prostate Imaging—Reporting and Data System: 2015, Version 2. Eur Urol 69:16–40

PubMed  Google Scholar 

Giganti F, Allen C, Emberton M, Moore CM, Kasivisvanathan V, PRECISION Study Group (2020) Prostate Imaging Quality (PI-QUAL): a new quality control scoring system for multiparametric magnetic resonance imaging of the prostate from the PRECISION trial. Eur Urol Oncol 3:615–619

PubMed  Google Scholar 

de Rooij M, Allen C, Twilt JJ et al (2024) PI-QUAL version 2: an update of a standardised scoring system for the assessment of image quality of prostate MRI. Eur Radiol. https://doi.org/10.1007/s00330-024-10795-4

Ahdoot M, Wilbur AR, Reese SE et al (2020) MRI-targeted, systematic, and combined biopsy for prostate cancer diagnosis. N Engl J Med 382:917–928

PubMed  PubMed Central  Google Scholar 

Siddiqui MM, Rais-Bahrami S, Truong H et al (2013) Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy. Eur Urol 64:713–719

PubMed  PubMed Central  Google Scholar 

Siddiqui MM, Rais-Bahrami S, Turkbey B et al (2015) Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. JAMA 313:390–397

CAS  PubMed  PubMed Central  Google Scholar 

Westphalen AC, McCulloch CE, Anaokar JM et al (2020) Variability of the positive predictive value of PI-RADS for prostate MRI across 26 centers: experience of the Society of Abdominal Radiology Prostate Cancer Disease-focused Panel. Radiology 296:76–84

PubMed  Google Scholar 

Englman C, Maffei D, Allen C et al (2024) PRECISE Version 2: Updated recommendations for reporting prostate magnetic resonance imaging in patients on active surveillance for prostate cancer. Eur Urol. https://doi.org/10.1016/j.eururo.2024.03.014

Abreu-Gomez J, Dias AB, Ghai S (2023) PI-RR: The prostate imaging for recurrence reporting system for MRI assessment of local prostate cancer recurrence after radiation therapy or radical prostatectomy-a review. AJR Am J Roentgenol 220:852–861

PubMed  Google Scholar 

Wysock JS, Rapoport E, Hernandez H, Gogaj R, Lepor H (2023) Biopsy assessment of oncologic control 3 years following primary partial gland cryoablation: a prospective cohort study of men with intermediate-risk prostate cancer. J Urol 210:454–464

PubMed  Google Scholar 

Ahn H, Hwang SI, Lee HJ et al (2023) Diagnostic performance of MRI for prediction of recurrent prostate cancer after high-intensity focused ultrasound: a systematic review and meta-analysis. Prostate Int 11:59–68

PubMed  Google Scholar 

Pausch AM, Elsner C, Rupp NJ, Eberli D, Hotker AM (2024) MRI-based monitoring of prostate cancer after HIFU: Inter-reader agreement and diagnostic performance of the PI-FAB score. Eur J Radiol 175:111463

PubMed  Google Scholar 

Gelikman DG, Kenigsberg AP, Mee Law Y et al (2024) Evaluating Diagnostic Accuracy and Inter-reader Agreement of the Prostate Imaging After Focal Ablation Scoring System. Eur Urol Open Sci 62:74–80

PubMed  PubMed Central  Google Scholar 

Light A, Mayor N, Cullen E et al (2024) The Transatlantic Recommendations for Prostate Gland Evaluation with Magnetic Resonance Imaging After Focal Therapy (TARGET): A Systematic Review and International Consensus Recommendations. Eur Urol 85:466–482

PubMed  Google Scholar 

Esengur OT, Gelikman DG, Law YM et al (2024) Comparison of Transatlantic Recommendations for Prostate Gland Evaluation with MRI after Focal Therapy (TARGET) and Prostate Imaging after Focal Ablation (PI-FAB) for Detecting Recurrent Prostate Cancer at Prostate MRI. Acad Radiol. https://doi.org/10.1016/j.acra.2024.09.051

Girometti R, Peruzzi V, Polizzi P et al (2024) Case-by-case combination of the prostate imaging reporting and data system version 2.1 with the Likert score to reduce the false-positives of prostate MRI: a proof-of-concept study. Abdom Radiol (NY) 49:4273–4285

PubMed  Google Scholar